Should we monitor more closely the dosage of 9α-fluorohydrocortisone in salt-losing congenital adrenal hyperplasia?

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue 6, 1998, Pages 733-737

  Afonso Lopes, L ^a   Dubuis, J M ^a   Vallotton, M B ^a   Sizonenko, P C ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

9 fluorohydrocortisone; Growth; Plasma renin activity; Salt losing congenital adrenal hyperplasia

Indexed keywords

BIOLOGICAL MARKER; FLUDROCORTISONE; RENIN;

ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG MECHANISM; DRUG MONITORING; FEMALE; HUMAN; MALE; PLASMA RENIN ACTIVITY; SALT LOSING NEPHRITIS;

EID: 0031784402     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1998.11.6.733     Document Type: Article

References (19)

1. Newns GH. Congenital adrenal hyperplasia. Arch Dis Child 1974; 49: 1-3.
2. Jansen M, Wit JM, Van Den Brande JL. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Acta Paediatr Scand 1981; 70: 229-233.
3. Hughes IA. Management of congenital adrenal hyperplasia. Arch Dis Child 1988; 63: 1399-1404.
4. Kuhnle U, Rösier A, Pareira JA, Gunczler P, Levine LS, New MI. The effects of long-term normalisation of sodium balance on linear growth in disorders with aldosterone deficiency. Acta Endocrinol 1983; 102: 577-582.
5. Hughes IA. Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia. Arch Dis Child 1974; 54: 350-355.
6. Miller WL. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994; 78: 241-246.
7. Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist. Palo Alto, CA: Standford University Press, 1959.
8. Sempé M, Pédron G. Courbes de croissance staturoponderale, étude longitudinale (1953-1970) Paris: Centre International de 1'Enfance.
9. Burr IM, Sizonenko PC, Kaplan SL, Grumbach MM. Hormonal changes in puberty: I. Correlation of serum luteinizing hormone and follicle stimulating hormone with stages of puberty, testicular size, bone age in normal boys. Pediatr Res 1970; 4: 25-35.
10. Sizonenko PC, Burr IM, Kaplan SL, Grumbach MM. Hormonal changes in puberty: II. Correlation of serum luteinizing hormone and follicle stimulating hormone with stages of puberty, testicular size, bone age in normal girls. Pediatr Res 1970; 4: 36-45.
11. Sizonenko PC, Paunier L. Hormonal changes in puberty: III: Correlation of plasma dehydroepiandro-sterone, testosterone and FSH and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature adrenarche. J Clin Endocrinol Metab 1975; 41: 894-904.
12. Sizonenko PC, Paunier L, Carmignac D: Hormonal changes in puberty: IV: Longitudinal study of adrenal androgen secretions. Horm Res 1976; 7: 288-302.
13. Godard C, Geering JM, Geering K, Vallotton MB. Plasma renin activity related to sodium balance, renal function and urinary vasopressin in the newborn infant. Pediatr Res 1979; 13:742-745.
14. Lopes LA, Catzeflis C, Cicotti I, Rev C, Sizonenko PC. Plasma 3α-androstanediol glucuronide in normal children and in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 1997; 48: 35-40.
15. Kley HK, Geisthövel W, Kruskemper HL. Effect of 9α-fluorohydrocortisone on hypothalamo-pituitary-adrenal axis. Acta Endocrinol 1973; 73: 417-426.
16. Rösier A, Levine LS, Schneider B, Novogroder M, New Ml. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977; 45: 500-512.
17. Schaison G, Couzinet B, Gourmelen M, Elkik F, Bougnères P. Angiotensin and adrenal steroidogenesis: Study of 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab 1980; 51: 1390-1394.
18. Hepp R, Grillet C, Peytremann A, Vallotton MB. Stimulation of corticosteroid biosynthesis by angiotensin I, [Des-Asp 1]-angiotensin I, angiotensin II and [Des-Asp 1]-angiotensin II in bovine adrenal fasciculata cells. Endocrinology 1977; 101: 717-725.
19. Voorhess ML. Congenital adrenal hyperplasia (defects in biosynthesis of corticosteroids and aldosterone). In: Gellis SS, Kagan BM, eds. Current Pediatric Therapy. Philadelphia, PA: W.B. Saunders, 1982; 291-296.